CYP2D6 Polymorphisms and Response to Codeine and Tramadol
active metabolites for analgesic efficacy [8]. The purpose of this Editorial is to discuss CYP2D6 polymorphisms and codeine non-response in pain populations
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
active metabolites for analgesic efficacy [8]. The purpose of this Editorial is to discuss CYP2D6 polymorphisms and codeine non-response in pain populations
most important tramadol metabolizing enzymes is CYP2D6. The CYP2D6 polymorphism leads to good, poor or no enzyme activity. Genetic testing helps in identification of high risk addicts whom to develop ... objective of…
receptor (44.8%), HER2/neu (26.9%) and advanced stage. Our results suggested that the CYP2D6*4 polymorphism plays an important role in the breast cancer etiology and might help in planning
T o assess the possibility of using CYP2D6*10 + CYP3A5*3 as
lack of bioactivation towards its active metabolite endoxifen that is mainly mediated by the polymorphic CYP2D6 enzyme for which distinct genetically determined functional variants are present in the general population…
Background: Different factors alter a patient’s susceptibility to adverse neuroleptic reactions
beta blockers and antidepressants. The aim of this study is to evaluate the CYP2D6, CYP2C9, CYP2C19 polymorphisms of shizophrenic and bipolar patients in the therapeutic response that allow the treatment
from the primary metabolite N-desmethyl-tamoxifen by the polymorphic cytochrome P450 (CYP) 2D6 enzyme. Distinct genetically determined functional CYP2D6 variants are present in the general population and…
patients [1]. In many cases, it is the result of genetic polymorphisms cytochromes involved in drug metabolism (CYP2D6, CYP2C19, CYP1A2) and/or drug transport (p-glycoprotein (MDR)) [2]. Pharmacogenetic testing…
decision-making to personalize dosing may both enhance efficacy and reduce adverse effects. Polymorphisms affect several pharmacodynamic and pharmacokinetic variables that modulate efficacy and adverse effects; however…
European Ibero-American for Population Pharmacogenetics) aimed to evaluate the most relevant CYPs genetic polymorphism (CYP2D6, CYP2C9, CYP2C19) in Hispanics from Ibero-America. An standardized protocol for genetic…
investigate the association between catechol-0-methyltrasferase (COMT) and cytochrome P450 D6 (CYP2D6*10) genetic polymorphisms and opioid consumption among cancer patients. Polymorphisms in the COMT rs4680 and CYP2D6…
individual differences of drug response. The life-threatening adverse reaction of codeine by CYP2D6 genetic polymorphism gives rise to safety issues. The people who have multiple copies of CYP2D6 active ... Korean. In…
Tamoxifen, It has four-fold PKC inhibitory activity and is also independent of CYP2D6 genetic polymorphism. I participated in a Phase II study demonstrating efficacy and safety of Endoxifen
action of CYP2C19 and CYP2D6 in the CNS suggest associations between suicidality, anxiety and other stress-related disorders and such CYP enzyme polymorphisms. Knowledge about the CNS specific action ... human and…
polymorphism is involved in the metabolism of tramadol. We investigated the effect of CYP2D6 gene polymorphism on tramadol metabolism by studying CYP2D6*1, CYP2D6*DUP, CYP2D6*4, and CYP2D6
cytochrome P450 (CYP) mainly CYP2D6 and CYP3A4 enzymes. Due to the genetic polymorphisms in CYP2D6 genes, high variation in the clinical outcomes of TAM treatment is observed among women
cytochrome P450 (CYP) mainly CYP2D6 and CYP3A4 enzymes. Due to the genetic polymorphisms in CYP2D6 genes, high variation in the clinical outcomes of TAM treatment is observed among women
cytochrome P450 (CYP) mainly CYP2D6 and CYP3A4 enzymes. Due to the genetic polymorphisms in CYP2D6 genes, high variation in the clinical outcomes of TAM treatment is observed among women
treatment clinical outcomes in breast cancer patients. The reported data suggest that polymorphisms in CYP2D6 and ER genotype might be useful in selecting women who would gain the highest benefit
For authors and organisers
Find the right journal for your paper and submit your manuscript.